<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>The Medical Xchange</provider_name><provider_url>https://themedicalxchange.com/en/</provider_url><title>National Survey Reveals Majority of PPI Users Achieve Inadequate Relief - The Medical Xchange</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="1LVwCmXnVb"&gt;&lt;a href="https://themedicalxchange.com/en/2012/06/03/digestive-disease-week-2012/"&gt;National Survey Reveals Majority of PPI Users Achieve Inadequate Relief&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://themedicalxchange.com/en/2012/06/03/digestive-disease-week-2012/embed/#?secret=1LVwCmXnVb" width="600" height="338" title="&#x201C;National Survey Reveals Majority of PPI Users Achieve Inadequate Relief&#x201D; &#x2014; The Medical Xchange" data-secret="1LVwCmXnVb" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://themedicalxchange.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://themedicalxchange.com/wp-content/uploads/2012/06/EX_7004_DDW_EN_Fig_1.PNG</thumbnail_url><thumbnail_width>960</thumbnail_width><thumbnail_height>720</thumbnail_height><description>San Diego &#x2013; Fewer than half of patients with gastroesophageal reflux disease (GERD) achieve adequate symptom relief from their current prescription of proton pump inhibitor (PPI) therapy, according to a large survey undertaken in the United States. Sponsored by the American Gastroenterological Association (AGA), the survey indicated that 55.3% of patients on a PPI continued to have sufficient symptoms to significantly disrupt their life. When compared to PPI users who were achieving adequate symptom control, those with persistent symptoms reported important limitations on activities of daily living.</description></oembed>
